Category: SLD

All Podcast Categories
S4-E46.3 - The Liver Meeting 2023: Updates with Key Opinion Leader, Naim Alkhouri

S4-E46.3 – The Liver Meeting 2023: Updates with Key Opinion Leader, Naim Alkhouri

This week on Surfing NASH, host Roger Green embarks on a series of one on one interviews with KOLs and patient advocates to talk about the Liver Meeting 2023 (held in Boston from November 10 – 14) and much more. In this conversation, friend of the podcast, Naim Alkhouri, joins to discuss this highly anticipated event as well as offer a glimpse into his current work and research interests.

S4-E46.2 - Anticipating TLM 2023 with Michael Betel

S4-E46.2 – Anticipating TLM 2023 with Michael Betel

This week on Surfing NASH, host Roger Green embarks on a series of one on one interviews with KOLs and patient advocates to talk about anticipations around the Liver Meeting 2023 (held in Boston from November 10 – 14) and much more. In this session, President of the Fatty Liver Alliance, Michael Betel,  joins to discuss this highly anticipated event, plus some additional key ideas around patient advocacy.

S4-E46.1 - The Liver Meeting 2023: Updates with Key Opinion Leader, Jörn Schattenberg

S4-E46.1 – The Liver Meeting 2023: Updates with Key Opinion Leader, Jörn Schattenberg

This week on Surfing NASH, host Roger Green embarks on a series of one on one interviews with KOLs and patient advocates to talk about the Liver Meeting 2023 (held in Boston from November 10 – 14) and much more. In this first conversation, Jörn Schattenberg joins to discuss this highly anticipated event as well as offer a glimpse into his current work and research interests.

S4-E45.1 - Meeting Professor Oren Shibolet

S4-E45.1 – Meeting Professor Oren Shibolet

In continuation of the Surfing NASH interview series, this week Roger Green talks to Professor Oren Shibolet, Head of Gastroenterology and Hepatology at the Tel Aviv Medical Center.

S4-E44.4 - How does MASH and MASLD differ in women compared to men?

S4-E44.4 – How does MASH and MASLD differ in women compared to men?

This final conversation covers the other paper discussed in the episoe at large, a literature review looking at how MASH and MASLD might differ in women compared to men. Roberta starts by noting the gap in literature about gender differences in MASH studies, and that women appear represented in most clinical trials.

S4-E44.2 - Investigating False Negative Screening Rates

S4-E44.2 – Investigating False Negative Screening Rates

This conversation starts with your Jörn returning to a key point from Roberta’s paper around a 38% false negative rate for FIB-4 screening. Jörn notes that while this feels like a high rate for false negatives, it might not present as much of a diagnostic challenge if treaters repeat the screening every 2 to 3 years.

S4-E42.5 - Final Recap of the 2023 SLD Summit: Takeaways and Looking Forward

S4-E42.5 – Final Recap of the 2023 SLD Summit: Takeaways and Looking Forward

The EASL SLD Summit aims at updating a global community of liver stakeholders on the most recent advances in SLD research, both pre-clinically and clinically, focusing on MASLD and tackling the issue of MetALD. In this episode, Jörn Schattenberg, Louise Campbell and Roger Green review the recently concluded meeting with faculty members Sven Francque and Hannes Hagström in two seperate interviews.

Sponsoring Partnerships!

Sponsoring partnerships with SurfingMASH present a multifaceted avenue for companies seeking to amplify their brand presence and engage with targeted audiences.